Business Context and Reporting Period
This Form 8-K filing by Edible Garden AG Inc. (EDBL) reports events occurring between May 4, 2022, and May 9, 2022. The primary event is the completion of an underwritten public offering of units consisting of common stock and warrants, alongside the appointment of new independent directors and the commencement of trading on The Nasdaq Capital Market.
Key Financial Metrics
The filing details the capital raised through the public offering but does not provide historical revenue, profit, cash flow, or debt metrics.
- Gross Proceeds: Approximately $14.7 million from the sale of 2,930,000 units.
- Over-Allotment Proceeds: Approximately $4,000 from the partial exercise of the over-allotment option (439,500 warrants).
- Maximum Potential Proceeds: Approximately $16.8 million if the full over-allotment option were exercised.
- Offering Price: $5.00 per Unit (1 share + 1 warrant).
- Underwriting Discount: 7.0% of the public offering price.
- Warrant Exercise Price: $5.00 per share for public warrants; $6.25 per share for Representative's warrants.
Material Changes
The filing does not present comparative financial periods. The material changes reported are structural and capital-related:
- Capital Structure: Issuance of 2,930,000 shares of common stock and corresponding warrants.
- Board Composition: Appointment of three new independent directors (Mathew McConnell, Tracy Nazzaro, and Ryan Rogers) to the Board and its committees.
- Trading Status: Common stock and warrants began trading on Nasdaq under symbols "EDBL" and "EDBLW."
Outlook, Risks, and Management Commentary
Management Actions and Agreements:
- Director Compensation: New independent directors will receive $150,000 annually ($75,000 cash, $75,000 restricted stock).
- Lock-Up Period: The Company, directors, officers, and 1%+ shareholders are restricted from selling shares for 180 days post-closing.
- Right of First Refusal: Maxim Group LLC has a 24-month right of first refusal to manage future equity, debt, or strategic transactions.
- Representative's Warrants: 117,200 warrants issued to the underwriter as compensation, exercisable after 180 days at $6.25/share.
Risks and Contingencies:
- The Company agreed to indemnify underwriters for liabilities arising from the Offering.
- The filing incorporates by reference the Underwriting Agreement and Warrant Agreement for complete terms.
Investor Verification Checklist
- Verify the final net proceeds after deducting the 7.0% underwriting discount and offering expenses.
- Confirm the exact number of shares issued upon the partial exercise of the over-allotment option (only warrants were exercised).
- Review the attached Exhibits 1.1, 4.1, and 4.2 for full terms of the Underwriting and Warrant Agreements.
- Monitor the 180-day lock-up expiration date for potential selling pressure from insiders.
- Check subsequent filings for the utilization of the remaining over-allotment option (if any) and the impact on share count.